News | Page 23 | Weill Department of Medicine

Residency Diversity Open House Hosts Another Successful Make Your Match Event

Attracting a record number of attendees, the WCM-NYP Residency Diversity Open House held its annual event, Make Your Match, on Saturday, September 18, 2021.Organized by the NYP/Weill Cornell residency programs, Weill Department of Medicine Office of Diversity, Cornell Center for Health Equity, and the Weill Cornell Diversity Center for Excellence, the Make Your Match event provides medical students with important information about the residency match process. At the same time, it offers a... Read More

Dr. Martinez and Colleagues Highlighted in NYP’s Advances Newsletter: Multipronged Management of Interstitial Lung Disease

Dr. Fernando J. Martinez, Chief, Division of Pulmonary and Critical Care Medicine, WDOM, and colleagues have been highlighted in NewYork-Presbyterian’s Advances newsletter for their cutting-edge work on the multipronged management of interstitial lung disease (ILD). With more than 200 pulmonary disorders that fall under the umbrella of ILD, patient evaluation, proper diagnosis, and determining the best treatment is of the utmost importance. Dr. Martinez and colleagues (Drs. Robert J. Kaner,... Read More

Key Finding Published in Cell on ILC3s and Protection Against Colorectal Cancer

In a collaborative study led by researchers from the WDOM’S Division of Gastroenterology and Hepatology and Division of Hematology and Medical Oncology, it has been found that an immune cell subset called innate lymphoid cells (ILC3s) play a role in protecting against colorectal cancer.Dr. Gregory Sonnenberg, senior author, Dr. Jeremy Goc, lead author, and the study’s co-author, Dr. Manish Shah, have discovered that ILC3s (which reside in the intestines) protect against colorectal cancer, in... Read More

Dr. Ndhlovu Appointed as Principal Investigator of the HOPE Collaboratory

Dr. Lishomwa NdhlovuAs part of a $26.5-million grant from the NIH, Dr. Lishomwa “Lish” Ndhlovu, Professor of Immunology in Medicine, Division of Infectious Diseases, will be serving as one of the Principal Investigators to lead the HOPE Collaboratory. The HOPE (HIV Obstruction by Programmed Epigenetics) Collaboratory represents a completely new strategy for curing HIV.The institutions involved in the HOPE Collaboratory, Weill Cornell Medicine, Gladstone Institute of Virology, and Scripps... Read More

Goncalves Lab at the Forefront of Research Showing How Fructose in the Diet Contributes to Obesity

Dr. Marcus DaSilva GoncalvesDr. Marcus DaSilva Goncalves, Ralph L. Nachman Research Scholar and Assistant Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, and colleagues have published a paper in Nature that has uncovered a key finding on how fructose in the diet contributes to obesity.In previous research published in 2019, Dr. Goncalves and team had shown that dietary fructose could increase tumor size in mouse models of colorectal cancer. The researchers had also... Read More

Dr. Jones Appointed as Principal Investigator of REACH: $28.5 Million NIH-funded Grant

Dr. Brad JonesDr. Brad Jones, Associate Professor of Immunology in Medicine, Division of Infectious Diseases, has been appointed to serve as Principal Investigator of REACH (Research Enterprise to Advance a Cure for HIV). As part of The Martin Delaney Collaboratories, which is an NIH flagship funding mechanism, Dr. Jones will be leading REACH in pursuit of a cure for HIV. Formed in late 2020, REACH builds on investigative elements of the BELIEVE Collaboratory. BELIEVE, created in 2016,... Read More

Documenting the Impact of HIV on the Host Epigenome During the Earliest Stages of HIV Infection

Dr. Ndhlovu and Dr. Corley Publish Pivotal Finding in PLOS PathogensDr. Lishomwa “Lish” Ndhlovu and Dr. Michael J. Corley, Division of Infectious Diseases, have published a breakthrough finding in PLOS Pathogens that shows abrupt and altered cell-type specific DNA methylation profiles in blood, seen during acute HIV infection, persist despite prompt initiation of antiretroviral therapy (ART).Dr. Michael CorleyDr. Lishomwa NdhlovuDNA methylation, an epigenetic marker, plays a key role in... Read More

Second Annual Meeting on Advances on Nuclear Topology and 3D Chromatin Architecture in Cancer

On Friday, September 24, 2021, the Second Annual Meeting on Advances on Nuclear Topology and 3D Chromatin Architecture in Cancer will be held as a FREE virtual symposium. The event has been organized by Dr. Ari Melnick, Gebroe Family Professor of Hematology-Oncology, Division of Hematology and Medical Oncology, along with colleagues from NYU Langone. The speakers will include Dr. Effie Apostolou, the division’s Raymond and Beverly Sackler Research Scholar, as well as guest speakers from the U.S... Read More

Tammy Snyder, MPH, Appointed as Chief Administrative Officer in the Weill Department of Medicine

Tammy Snyder, MPHTammy Snyder, MPH, has been appointed as Chief Administrative Officer in the Weill Department of Medicine effective August 8, 2021. In this key leadership role, Tammy will be directing administrative and business activities within the department, including finance, accounting, research administration, clinical operations, capital planning, academic appointments, and education. With a focus on developing operational and fiscal solutions, Tammy will work collaboratively with the... Read More

Dr. Brown Appointed as Chief of the Division of Gastroenterology and Hepatology

Dr. Robert S. Brown, Jr.The Weill Department of Medicine (WDOM) is pleased to announce that Robert S. Brown, Jr., M.D., M.P.H. has been appointed as the new Chief of the Division of Gastroenterology and Hepatology effective August 1, 2021. Dr. Brown is the co-founder and Director of the bi-campus Center for Liver Disease and Transplantation at NewYork-Presbyterian Hospital. He has been an integral part of the liver transplant effort at Weill Cornell since 1999 and joined the faculty full-time... Read More